Licensed medical cannabis prescriptions are currently only prescribed through the NHS for certain individuals with severe epilepsies (Dravet syndrome, Lennox-Gastaut syndrome, and tuberous sclerosis complex), spasticity associated with multiple sclerosis, and nausea caused by chemotherapy.
Fewer than 5 individuals have been successful in having their prescription for unlicensed medical cannabis products funded by the NHS.
